Valeant Pharmaceuticals International Inc.?s hostile bid for Cephalon Inc. is so low that Valeant could raise the offer by 15 percent and still pay less than any drug takeover in history.
Source: http://www.businessweek.com/news/2011-03-31/valeant-bid-for-cephalon-still-lowest-with-15-boost-real-m-a.html
apple iphone news apple macbook news apple stock news microsoft news
No comments:
Post a Comment